Key topics include results from the Phase 3 trial of Libtayo for high-risk cutaneous squamous cell carcinoma and data on linvoseltamab for relapsed or refractory multiple myeloma. Other research ...

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

Sanofi and Regeneron’s checkpoint inhibitor Libtayo has become the first immunotherapy to improve survival when used as a second-line therapy in cervical cancer, setting up regulatory filings ...

A Colorado-based hospitality company is bringing its brand of adventure-focused lodging to Northwest Arkansas.Campfire Ranch, a company known for lodging near recreational destinations ...

Reports of a plane crash emerged from the Wood Ranch area in Simi Valley on Saturday. Locals posted photos on social media, showing smoke coming out of homes. Authorities have yet to issue a ...

Regeneron continues to deliver growth on top/bottom line in the near to longer-term with Dupi and Libtayo, the analyst tells investors in a research note.

The Jalisco New Generation Cartel, a powerful drug trafficking group, allegedly used the ranch in Jalisco state to train newly recruited gunmen, senior officials have said. The discovery of human ...

Highlights from the ASCO presentations will include results from the Phase 3 C-POST trial, which explores the adjuvant use of PD-1 inhibitor Libtayo in high-risk cutaneous squamous cell carcinoma ...

Regeneron Pharmaceuticals is poised for an eventful month, highlighting exciting advancements in their cancer and respiratory disease treatments at upcoming conferences. Following a week where the ...

The Trump administration has dropped charges against a South Dakota ranching family who were accused of stealing federal land. Charles and Heather Maude were embroiled in a bitter dispute with ...